Showing posts with label Women Healthcare Market. Show all posts
Showing posts with label Women Healthcare Market. Show all posts

Monday 1 March 2021

Women Healthcare Market | Size, Share, Trend, Industry Statistics, Comprehensive Analysis and Top Countries data by Forecast to 2023

 Women Healthcare Market Analysis 


The global women healthcare market is predicted to grow at a 5.04% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR) report. Women's health, simply put, is a branch of medicine which focuses on the diagnosis and treatment of conditions and diseases which affect the emotional and physical well-being of a woman. It includes a huge range of focus areas and specialties such as gynecology, sexually transmitted infections, birth control, ovarian cancer, breast cancer and other types of female cancers, sexual health, childbirth and pregnancy, osteoporosis, hormone therapy and menopause, mammography, and benign conditions that affect the functioning of female reproductive organs. 

Request a Sample Copy to Understand the Impact of COVID-19 On Women Health Market @ https://www.marketresearchfuture.com/sample_request/3121  


Various factors are propelling the women healthcare market growth. These factors, as per the new Market Research Future (MRFR) report, include increasing geriatric women population, increasing adoption of unhealthy lifestyle, launch of new medicines for women, favorable policies undertaken by the government for raising awareness and improving women’s health, and rising incidence of obesity, depression, menstrual health-related disorders, anemia, osteoarthritis, and osteoporosis. Additional factors propelling market growth include technological advancements, increasing women’s health issues, change in government regulations, and investment made by market players for commercialization and research and development. 


Women Healthcare Market Segmentation


The MRFR report provides an all-inclusive segmental analysis of the women healthcare market on the basis of diagnosis, treatment, indications, and end users. 


Based on indication, the women healthcare market is segmented into gynecologic cancer, polycystic ovary syndrome, reproductive health management, infertility, postmenopausal osteoporosis, and others. The gynecologic cancer segment is again segmented into ovarian, breast, and other forms of cancer. Of these, the postmenopausal osteoporosis segment will have the largest share in the market over the forecast period. Factors pushing the growth of the segment include the presence of several key players, ongoing R&D activities, the launch of new drugs to treat menopausal osteoporosis, and the rise in the female population aged 40 and above. 


Based on diagnosis, the global women healthcare market is segmented into biopsies, ovulation testing, diagnostic imaging tests, bone densitometry, and others. 


Based on treatment, the women healthcare market is segmented into surgeries, therapeutics, and others. 


Based on end users, the women healthcare market is segmented into research institutes, gynecology centers, hospitals and clinics, and others. Among these, hospitals and clinics will dominate the market over the forecast period as a higher proportion of female patients visit hospitals and clinics both for diagnosis as well as treatment of different health issues. 


Women Healthcare Market Regional Analysis


By region, the women healthcare market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period and is predicted to touch USD 21, 782.6 million by 2023. Factors pushing growth in this region include the presence of a well-developed economy, favorable initiatives undertaken for promoting women healthcare, the presence of several key market players, favorable reimbursement, commercialization and approval of products, and increasing awareness regarding women’s health. 


The women healthcare market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors propelling growth in the region include increasing incidence of infertility, osteoarthritis, and other forms of women-related health problems due to stress, growing awareness about women’s health, and initiatives undertaken by the government for raising awareness and reimbursement. 


The women healthcare market in Europe is predicted to have a favorable growth over the forecast period while that in the MEA is likely to have limited growth over the forecast period chiefly due to the high price of diagnosis and treatment. 

 

Women Healthcare Market Key Players 


Key players profiled in the global women healthcare market report include Teva Pharmaceuticals (Israel), Pfizer Inc., (US), Merck & Co., Inc., (US), Eli Lilly Company (US), Becton Dickinson and Company (US), Bayer AG (Germany), Amgen (California), and Allergan plc. (Ireland). 

 

Industry News 


Oct 2019: Qure4u, a renowned patient engagement solution provider, has joined hands with Unified Women’s Healthcare, a leading multi-state organization that is dedicated to advance the transformation of female healthcare in the US. Qure4u’s digital engagement tool will better help Unified-affiliated Ob-Gyn providers, especially when engaging with patients. 

 

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/women-Healthcare-market-3121 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Wednesday 24 February 2021

Women Healthcare Market Future Growth, Development, Revenue, Top Key Players Analysis and Growth Factors | Impact of COVID-19

 The global women healthcare market is growing pervasively, mainly due to spreading awareness about the importance of women’s wellbeing. Women’s health status correlates with their social standing; hence, countries across the world focus on strengthening women’s health. The governments of these countries understand the pivotal role that women healthcare can play in building a nation and therefore support & spend increasingly on technologies, medicines, and treatments required to maintain their welfare. 

Request a Sample Copy to Understand the Impact of COVID-19 On Women Health Market @ https://www.marketresearchfuture.com/sample_request/3121   

According to Market Research Future (MRFR), the global women healthcare market is poised to garner exponential accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register over 5.04% CAGR throughout the forecast period (2017-2023).

Factors increasing the market demand include the lack of access to family planning programs, unwanted pregnancies, unsafe abortions & injuries associated with abortions, complications about the frequent & risky pregnancies, unavailability of follow-up care, sexually transmitted diseases & infections, and other psychological problems related to women health.

Chronic malnutrition among girls & women in the dominating male society and gender-biased systems are equally affecting women’s health, workplace, economic conditions, and sense of wellbeing. Simultaneously, the growing number of working women, especially in developing countries and the increasing awareness towards the advantages of women’s care, is propelling the market growth. 

However, factors like unmet medical needs are anticipated to restrict the market growth. Nevertheless, technological advancements transpired in healthcare are expected to foster market growth.

Global Women Healthcare Market – Segments

The report is segmented into four market dynamics to widen the scope of understanding,

By Indication : Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer, and others.

By Diagnosis & Treatment : Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, and others) and Treatment (Therapeutics, surgeries, and others) 

By End-users : Hospitals & Clinics, Gynecology Centers, and Research Institutes, among others. 

By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Women Healthcare Market - Regional Analysis

North America leads the global women healthcare market, due to the increasing initiatives promoting women’s health and wellness. Additionally, the presence of well-developed healthcare infrastructure and leading players is supporting the regional market growth. Also, increasing emphasis on diagnosis and continuous monitoring of diseases associated with women, especially propel the growth of the regional market. 

Furthermore, the high prevalence of various chronic diseases among women and the funding support from the companies, private organization, and government associations to improve women healthcare in the region drive the growth of the regional market. 

The women healthcare market in the European region takes the second leading position. The resurging economy plays an important role in supporting the growth of the regional market, availing the best possible healthcare and increasing the per capita healthcare expenditures specially designed for women. Besides, government support that encourages the players to develop high-quality technologies for women’s health and wellness and favorable reimbursement policies are fostering the growth in the regional market. 

The Asia Pacific women healthcare market is rapidly emerging as a profitable market globally. The prevalence of chronic diseases among women populaces is a key driving force behind the regional market growth. Moreover, factors such as the proliferating healthcare sector and spreading awareness among individuals towards women’s health and wellness and the availability of various care units drive the growth of the market in the region.

Global Women Healthcare Market   - Competitive Analysis

Fiercely competitive, the global women healthcare market appears to be fragmented with the presence of several well-established as well as small players. These players incorporate strategic initiatives such as collaboration, acquisition, expansion, strategic partnership, and technology launch. Leading players are investing substantially in R&D and clinical trials to develop effective drugs. 

Major Players: 

Key players leading the global women healthcare market include Amgen (California), Allergan plc. (Ireland), Bayer AG (Germany), Eli Lilly Company (US), Becton Dickinson and Company (US), Merck & Co., Inc., (US), Teva Pharmaceuticals (Israel), and Pfizer Inc., (US), among others. 

Industry/Innovation/ Related News:

August 26, 2019 ---- Amgen Inc. (the US), a multinational biopharmaceutical company announced that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers Squibb Company to acquire worldwide rights to Otezla and certain related assets and liabilities. Worldwide rights align with Amgen’s international presence and global expansion objectives. 

Otezla (apremilast) is the only oral, non-biologic treatment for psoriasis and psoriatic arthritis. Amgen believes that the acquisition of Otezla can offer many benefits, such as Support of increased R&D investment in 2020 to advance Amgen’s innovative pipeline of first-in-class molecules.  Further, the partnership would also enable intellectual property exclusivity through at least 2028 in the US without interrupting deployment of Amgen’s capital allocation priorities. 

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/women-Healthcare-market-3121 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.